Tenaya Therapeutics, Inc. (TNYA): Insider Trading, Congress Trades & Research | Tormere

TNYA

$0.56-0.28%website ↗⬇ financials (.py)

Tenaya Therapeutics, Inc.

Market Cap

$122M

Live price × shares (2026-09-17)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

2.89

60mo monthly vs SPY

P/E (TTM)

N/M

Price / TTM net income

P/S (TTM)

—

Price / TTM revenue

P/B

1.8

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

24.31x

Sell Rate (90d)

311.32/mo

Sell Baseline

31.83/mo

Unique Sellers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-17	2026-08-17	Ali Faraz	Director & Chief Executive Officer	Sale	22.2K	$0.71	$16K	417.8K	View
2026-08-17	2026-08-17	Tingley Whittemore	Chief Medical Officer	Sale	5,787	$0.71	$4K	214.1K	View
2026-05-18	2026-05-19	Ali Faraz	Director & Chief Executive Officer	Sale	3,390	$0.79	$3K	440.0K	View
2026-05-18	2026-05-19	Tingley Whittemore	Chief Medical Officer	Sale	3,121	$0.79	$2K	215.5K	View
2026-05-18	2026-05-19	Higa Tomohiro	SVP, Finance	Sale	1,485	$0.79	$1K	118.3K	View

1–5 of 8

1 / 2

Reporting Insiders

Faraz Ali
Director & Chief Executive Officer
4 transactions · last 2026-08-17
Whittemore Tingley
Chief Medical Officer
3 transactions · last 2026-08-17
Faraz Ali
Director & Chief Executive Officer
1 transaction · last 2026-05-18
Whittemore Tingley
Chief Medical Officer
1 transaction · last 2026-05-18
Tomohiro Higa
SVP, Finance
8 transactions · last 2026-05-18

Recent News

TNYA Oct 2026 2.500 call (TNYA261016C00002500) interactive stock chart

Yahoo Finance UK · 2026-09-29

TNYA News | TENAYA THERAPEUTICS INC (NASDAQ:TNYA)

ChartMill · 2026-09-26

Tenaya Therapeutics, Inc. (TNYA) Presents at H.C. Wainwright 28th Annual Global Investment Conference Transcript

SeekingAlpha · 2026-09-17

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Yahoo · 2026-09-14

FDA Grants Regenerative Medicine Advanced Therapy Designation To Tenaya Therapeutics’ TN-401, Gene Therapy Candidate For Treatment Of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Benzinga · 2026-09-14

$TNYA stock is up 8% today. Here's what we see in our data.

quiverquant.com · 2026-09-14

Treasury yields rise as investors raise bets on Fed rate hike: AlphaCheck

Yahoo · 2026-09-10

Tenaya Therapeutics to Participate in Upcoming September Investor Conferences

Yahoo Finance · 2026-09-03

Israel Englander group takes passive stake in Tenaya Therapeutics (TNYA)

Stock Titan · 2026-08-24

Tenaya Therapeutics Eyes Q4 Updates for Cardiac Gene Therapies, TN-301

Yahoo Finance · 2026-08-18

Tenaya Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

Yahoo Finance · 2026-08-05

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Yahoo Finance · 2026-07-15

Piper Sandler reiterates Overweight on Tenaya stock, $40 target

Investing.com · 2026-07-06

Tenaya Therapeutics Appoints Eric Hyllengren as Chief Financial Officer

Yahoo Finance · 2026-06-29

Tenaya Therapeutics Announces Interim Data from MyPEAK™-1 Showing Treatment of MYBPC3-associated HCM with TN-201 Gene Therapy Resulted in Consistent Signs of Cardiac Remodeling and Reductions in Symptoms

Yahoo Finance · 2026-06-03

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-08-17	Ali Faraz	S	5,020	$3,562.69
2026-08-17	Ali Faraz	S	3,969	$2,817.2
2026-08-17	Ali Faraz	S	5,837	$4,142.52
2026-08-17	Tingley Whittemore	S	2,279	$1,617.63
2026-08-17	Tingley Whittemore	S	1,871	$1,328.04